相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
SOCS1 blacks G1-S transition in hepatocellular carcinoma by reducing the stability of the CyclinD1/CDK4 complex in the nucleus
Jun Ding et al.
AGING-US (2020)
Molecular therapies for HCC: Looking outside the box
Sandrine Faivre et al.
JOURNAL OF HEPATOLOGY (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
The application and prospect of CDK4/6 inhibitors in malignant solid tumors
Qi Du et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Synergistic anti-tumor activity of miriplatin and radiation through PUMA-mediated apoptosis in hepatocellular carcinoma
Hironori Tanaka et al.
JOURNAL OF GASTROENTEROLOGY (2020)
CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
Dayong Xiao et al.
PEERJ (2020)
RMI2 plays crucial roles in growth and metastasis of lung cancer
Weixiang Zhan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A unified model for the G1/S cell cycle transition
Samuel Hume et al.
NUCLEIC ACIDS RESEARCH (2020)
The multiple mechanisms that regulate p53 activity and cell fate
Antonina Hafner et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis
Jinhui Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Insights into the success and failure of systemic therapy for hepatocellular carcinoma
Jordi Bruix et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53
Yingchao Wang et al.
ONCOGENESIS (2019)
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
Franco Trevisani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Transcribing malignancy: transcription-associated genomic instability in cancer
B. Boulianne et al.
ONCOGENE (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma
Roland Sonntag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
Quentin Bayard et al.
NATURE COMMUNICATIONS (2018)
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2018)
Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov et al.
NATURE REVIEWS CANCER (2018)
Tumor Evolution as a Therapeutic Target
Nabil Amirouchene-Angelozzi et al.
CANCER DISCOVERY (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
June-Koo Lee et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
The RTR Complex Partner RMI2 and the DNA Helicase RTEL1 Are Both Independently Involved in Preserving the Stability of 45S rDNA Repeats in Arabidopsis thaliana
Sarah Roehrig et al.
PLOS GENETICS (2016)
Loss of RMI2 Increases Genome Instability and Causes a Bloom-Like Syndrome
Damien F. Hudson et al.
PLOS GENETICS (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure
Alessandro Granito et al.
DIGESTIVE AND LIVER DISEASE (2015)
Multifaceted role of the Topo IIIα-RMI1-RMI2 complex and DNA2 in the BLM-dependent pathway of DNA break end resection
James M. Daley et al.
NUCLEIC ACIDS RESEARCH (2014)
Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo
R. Sonntag et al.
CELL DEATH & DISEASE (2014)
Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases
Sara Marinelli et al.
HEPATITIS MONTHLY (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Downregulation of Gadd45β Expression by Hepatitis C Virus Leads to Defective Cell Cycle Arrest
Martin R. Higgs et al.
CANCER RESEARCH (2010)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
More complexity to the Bloom's syndrome complex
Yilun Liu et al.
GENES & DEVELOPMENT (2008)
BLAP18/RMI2, a novel OB-fold-containing protein, is an essential component of the Bloom helicase-double Holliday junction dissolvasome
Thiyam Ramsing Singh et al.
GENES & DEVELOPMENT (2008)
分享论文
